Outcomes and management of viral hepatitis and human immunodeficiency virus co-infection in liver transplantation

Table 2 Summary of outcomes post orthotopic liver transplant in hepatitis B virus/human immunodeficiency virus co-infection

Ref.	Study period	Country	n	Median follow-up (mo)	Survival	Graft survival	Comments
Coffin et al[49]	2001-2007	United States	22	42	85% 1 yr	85% 1 yr	About 50% had detectable HBV pre transplant
					85% 3 yr	85% 3 yr
Tateo et al[97]	1999-2007	France	13	32	100%	100%	1 co-infected with HDV, 2 with HCV, 4 with HCV and HDV
Anadol et al[96]	1997-2011	Germany	10	611	90% 1 yr	NR
					80% 5 yr
Schreibman et al[98]	1999-2006	United States	8	NR	75% 1 yr	NR	2 co-infected with HCV, 1 fulminant hepatic failure
					75% 3 yr
Norris et al[99]	1995-2003	United Kingdom	4	22	100% 1 yr	NR

¹For entire series. HBV: Hepatitis B virus; HCV: Hepatitis C virus; NR: Not reported; HDV: Hepatitis D virus.